Medical Dialogues15h
Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1
Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Le Lézard3h
Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
Akeso Inc. (9926.HK) ("Akeso", "the Company") released its 2024 annual report, emphasizing the company's key achievements in drug research, clinical development, and commercialization. In 2024, Akeso ...
Targeted Oncology11h
The Targeted Pulse: Explaining Survivorship Care and Other Positive Developments Across Cancers
Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.